Inadequacies in antiretroviral therapy use among Aboriginal and other Canadian populations

References

• Andersen , R. , Bozzette , S. , Shapiro , M. , St Clair , P. , Morton , S. Crystal , S. 2000 . Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study . Health Services Research , 35 ( 2 ) : 389 – 416 .
   PubMed Web of Science ®Google Scholar
• Bangsberg , D.R. , Hecht , F.M. , Charlebois , E.D. , Zolopa , A.R. , Holodniy , M. Sheiner , L. 2000 . Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population . AIDS , 14 ( 4 ) : 357 – 66 .
   PubMed Web of Science ®Google Scholar
• BC CDC HIV/AIDS Update Annual (2001) . Vancouver : BC Centre for Disease Control .
   Google Scholar
• Bouhnik , A.D. , Chesney , M. , Carrieri , P. , Gallais , H. , Moreau , J. Moatti , J.P. 2002 . Nonadherence among HIV-infected injecting drug users: the impact of social instability . Journal of Acquired Immune Deficiency Syndromes , 31 ( Suppl 3 ) : S149 – 53 .
   PubMed Web of Science ®Google Scholar
• Broadhead , R.S. , Heckathorn , D.D. , Altice , F.L. , van Hulst , Y. , Carbone , M. Friedland , G.H. 2002 . Increasing drug users’ adherence to HIV treatment: results of a peer-driven intervention feasibility study . Social Science & Medicine , 55 ( 2 ) : 235 – 46 .
   PubMed Web of Science ®Google Scholar
• Carpenter , C.C. , Cooper , D.A. , Fischl , M.A. , Gatell , J.M. , Gazzard , B.G. Hammer , S.M. 2000 . Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel.[comment] . JAMA , 283 ( 3 ) : 381 – 90 .
   PubMed Web of Science ®Google Scholar
• CDC (2002) . Hepatitis C Virus and Coinfection, from http://www.cdc.gov/idu
   Google Scholar
• Chaisson , R.E. , Keruly , J.C. and Moore , R.D. 1995 . Race, sex, drug use, and progression of human immunodeficiency virus disease . New England Journal of Medicine , 333 ( 12 ) : 751 – 56 .
   PubMed Web of Science ®Google Scholar
• Cohen , M. , Deamant , C. , Barkan , S. , Richardson , J. , Young , M. Holman , S. 2000 . Domestic violence and childhood sexual abuse in HIV-infected women and women at risk for HIV.[comment] . American Journal of Public Health , 90 ( 4 ) : 560 – 65 .
   PubMed Web of Science ®Google Scholar
• Craib , K.J. , Spittal , P.M. , Wood , E. , Laliberte , N. , Hogg , R.S. Li , K. 2003 . Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver . CMAJ , 168 ( 1 ) : 19 – 24 .
   PubMed Web of Science ®Google Scholar
• Hammer , S.M. , Squires , K.E. , Hughes , M.D. , Grimes , J.M. , Demeter , L.M. Currier , J.S. 1997 . A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team . New England Journal of Medicine , 337 ( 11 ) : 725 – 33 .
   PubMed Web of Science ®Google Scholar
• Health Canada (2001) . HIV/AIDS Among Aboriginal Persons in Canada . Ottawa : Bureau of HIV/AIDS, STD and TB Update Series , 1 – 8 .
   Google Scholar
• Health Canada . 2002 . HIV/AIDS EPI Updates , 34 – 38 . Ottawa : Population and Public Health Branch .
   Google Scholar
• Hogg , R.S. , Yip , B. , Kully , C. , Craib , K.J. , O'Shaughnessy , M.V. Schechter , M.T. 1999 . Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.[comment] . Canadian Medical Association Journal , 160 ( 5 ) : 659 – 65 .
   PubMed Web of Science ®Google Scholar
• Hogg , R.S. , Yip , B. , Chan , K.J. , Wood , E. , Craib , K.J. O'Shaughnessy , M.V. 2001 . Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy . JAMA , 286 ( 20 ) : 2568 – 77 .
   PubMed Web of Science ®Google Scholar
• Hogg , R. S , Heath , K. , Bangsberg , D. , Yip , B. , Press , N. O'Shaughnessy , M.V. 2002 . Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up . AIDS , 16 ( 7 ) : 1051 – 58 .
   PubMed Web of Science ®Google Scholar
• Jacobson , M.A. and French , M. 1998 . Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy . AIDS , 12 ( Suppl A ) : S157 – 63 .
   PubMedGoogle Scholar
• Junghans , C. , Ledergerber , B. , Chan , P. , Weber , R. and Egger , M. 1999 . Sex differences in HIV-1 viral load and progression to AIDS. Swiss HIV Cohort Study . Lancet , 353 ( 9152 ) : 589; discussion 590 – 91 .
   Google Scholar
• Kitahata , M. M , Van Rompaey , S.E. , Dillingham , P.W. , Koepsell , T.D. , Deyo , R.A. Dodge , W. 2003 . Primary care delivery is associated with greater physician experience and improved survival among persons with AIDS . Journal of General Internal Medicine , 18 ( 2 ) : 95 – 103 .
   PubMed Web of Science ®Google Scholar
• Levine , A.M. 2002 . Evaluation and management of HIV-infected women . Annals of Internal Medicine , 136 ( 3 ) : 228 – 42 .
   PubMed Web of Science ®Google Scholar
• Liebschutz , J.M. , Feinman , G. , Sullivan , L. , Stein , M and Samet , J. 2000 . Physical and sexual abuse in women infected with the human immunodeficiency virus: increased illness and health care utilization . Archives of Internal Medicine , 160 ( 11 ) : 1659 – 64 .
   PubMed Web of Science ®Google Scholar
• Lucas , G.M. , Chaisson , R.E. and Moore , R.D. 1999 . Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions . Annals of Internal Medicine , 131 ( 2 ) : 81 – 87 .
   PubMed Web of Science ®Google Scholar
• Martin-Carbonero , L , Soriano , V , Valencia , E , Garcia-Samaniego , J , Lopez , M and Gonzalez-Lahoz , J. 2001 . Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients . AIDS Research & Human Retroviruses , 17 ( 16 ) : 1467 – 71 .
   PubMed Web of Science ®Google Scholar
• Monforte Ade , A. , Bugarini , R. , Pezzotti , P. , De Luca , A. , Antinori , A. Mussini , C. 2001 . Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART . Journal of Acquired Immune Deficiency Syndromes , 28 ( 2 ) : 114 – 23 .
   PubMed Web of Science ®Google Scholar
• Montaner , J.S. , Reiss , P. , Cooper , D. , Vella , S. , Harris , M. Conway , B. 1998 . A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study . JAMA , 279 ( 12 ) : 930 – 37 .
   PubMed Web of Science ®Google Scholar
• Mostashari , F. , Riley , E. , Selwyn , P.A. and Altice , F.L. 1998 . Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility . Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology , 18 ( 4 ) : 341 – 48 .
   PubMedGoogle Scholar
• Office of the Provincial Health Officer . 2001 . The Health and Well Being of Aboriginal People in British Columbia , 123 – 125 . Victoria : Ministry of Health Planning .
   Google Scholar
• Opravil , M. , Cone , R.W. , Fischer , M. , Vernazza , P.L. , Bassetti , S. Lorenzi , P. 2000 . Effects of early antiretroviral treatment on HIV-1 RNA in blood and lymphoid tissue: a randomized trial of double versus triple therapy. Swiss HIV Cohort Study . Journal of Acquired Immune Deficiency Syndromes , 23 ( 1 ) : 17 – 25 .
   PubMed Web of Science ®Google Scholar
• Palepu , A. , Tyndall , M. , Yip , B. , O'Shaughnessy , M.V. , Hogg , R.S. and Montaner , J.S. 2003 . Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use . Journal of Acquired Immune Deficiency Syndromes , 32 ( 5 ) : 522 – 26 .
   PubMed Web of Science ®Google Scholar
• Palepu , A. , Yip , B. , Miller , C. , Strathdee , S.A. , O'Shaughnessy , M.V. Montaner , J.S. 2001 . Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use . AIDS , 15 ( 3 ) : 423 – 24 .
   PubMed Web of Science ®Google Scholar
• Poundstone , K.E. , Chaisson , R.E. and Moore , R.D. 2001 . Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy . AIDS , 15 ( 9 ) : 1115 – 23 .
   PubMed Web of Science ®Google Scholar
• Prins , M. , Robertson , J.R. , Brettle , R.P. , Aguado , I.H. , Broers , B. Boufassa , F. 1999 . Do gender differences in CD4 cell counts matter? . AIDS , 13 ( 17 ) : 2361 – 64 .
   PubMed Web of Science ®Google Scholar
• Rhone , S.A. , Hogg , R.S. , Yip , B. , Sherlock , C. , Conway , B. Schechter , M.T. 1998 . Do dual nucleoside regimens have a role in an era of plasma viral load-driven antiretroviral therapy? . Journal of Infectious Diseases , 178 ( 3 ) : 662 – 68 .
   PubMed Web of Science ®Google Scholar
• Statistics Canada . 1998 . 1996 Census: Aboriginal data , 1 – 13 . Ottawa : Statistics Canada .
   Google Scholar
• Strathdee , S.A. , Palepu , A. , Cornelisse , P.G. , Yip , B. , O'Shaughnessy , M.V. Montaner , J.S. 1998 . Barriers to use of free antiretroviral therapy in injection drug users.[comment] . JAMA , 280 ( 6 ) : 547 – 49 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Montaner , J.S. , Chan , K. , Tyndall , M.W. , Schechter , M.T. Bangsberg , D. 2002 . Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996 . AIDS , 16 ( 15 ) : 2065 – 72 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Montaner , J. , Yip , B. , Schechter , M. , & MV OS , R H. (2003) . Prevalence and correlates of untreated HIV-1 infection among persons who have died in the era of modern antiretroviral therapy . Journal of Infectious Diseases . 188 (8) , 1164 – 1170 .
   PubMed Web of Science ®Google Scholar
• Wood , E. , Montaner , J. , Yip , B. , Tyndall , M. , Schechter , M. , & O'Shaughnessy , M. , et al. (2003) . Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users . CMAJ , 169 (7) , 656 – 661 .
   PubMed Web of Science ®Google Scholar
• Zaccarelli , M. , Barracchini , A. , De Longis , P. , Perno , C.F. , Soldani , F. Liuzzi , G. 2002 . Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapine . AIDS Patient Care & Stds , 16 ( 2 ) : 67 – 73 .
   PubMed Web of Science ®Google Scholar